# ORAMED PHARMACEUTICALS INC.: Form D filings

ORAMED PHARMACEUTICALS INC., a pharmaceuticals company in Jerusalem, Israel, filed 9 Form D notices with the SEC between 2011 and 2014. The latest, on November 14, 2014, reports an offering of $5 million with nothing sold yet to 1 investor.

Find out what ORAMED PHARMACEUTICALS INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20ORAMED%20PHARMACEUTICALS%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=ORAMED%20PHARMACEUTICALS%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Foramed-pharmaceuticals-inc-1176309)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20ORAMED%20PHARMACEUTICALS%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=ORAMED%20PHARMACEUTICALS%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Foramed-pharmaceuticals-inc-1176309)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: HI-TECH PARK 2/4 GIVAT-RAM, Jerusalem, Israel, 91390
- Phone: +972-2-566-0001
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1176309

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 14, 2014 | New notice | $5,000,000 | $0 | $5,000,000 | 1 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1176309/000117891314003565/0001178913-14-003565-index.htm) |
| Jan 3, 2013 | New notice | $474,500 | $31,500 | $443,000 | 1 | Mar 14, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1176309/000117891313000027/0001178913-13-000027-index.htm) |
| Jan 2, 2013 | New notice | $76,360 | $76,360 | $0 | 1 | Dec 12, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1176309/000117891313000021/0001178913-13-000021-index.htm) |
| Sep 27, 2012 | Amendment | $1,675,676 | $1,000,000 | $675,676 | 1 | Aug 28, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1176309/000117891312002740/0001178913-12-002740-index.htm) |
| Sep 19, 2012 | Amendment | $1,675,676 | $1,000,000 | $675,676 | 1 | Aug 28, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1176309/000117891312002687/0001178913-12-002687-index.htm) |
| Sep 12, 2012 | New notice | $1,675,676 | $1,000,000 | $675,676 | 1 | Aug 28, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1176309/000117891312002620/0001178913-12-002620-index.htm) |
| Apr 13, 2011 | Amendment | $5,191,312 | $3,356,000 | $1,835,312 | 8 | Nov 18, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1176309/000114420411021714/0001144204-11-021714-index.htm) |
| Feb 22, 2011 | Amendment | $4,665,375 | $3,016,000 | $1,649,375 | 6 | Nov 18, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1176309/000114420411010141/0001144204-11-010141-index.htm) |
| Jan 18, 2011 | New notice | $5,000,000 | $2,350,000 | $2,650,000 | 3 | Nov 18, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1176309/000114420411002602/0001144204-11-002602-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Miriam Kidron | Executive Officer, Director |  |
| Yifat Hen Zommer | Executive Officer |  |
| Leonard Sank | Director |  |
| Harold Jacob | Director |  |
| Nadav Kidron | Executive Officer, Director |  |
| Michael Berelowitz | Director |  |
| Joshua Hen Hexter | Executive Officer |  |
| Gerald M Ostrov | Director |  |

[Every Form D from the week of Nov 10, 2014](https://specstream.ai/data/form-d/week/2014-11-10) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what ORAMED PHARMACEUTICALS INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).